Critical Analysis: Adagio Medical (NASDAQ:ADGM) and Autonomix Medical (NASDAQ:AMIX)

Adagio Medical (NASDAQ:ADGM) and Autonomix Medical (NASDAQ:AMIX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, profitability, institutional ownership, earnings, valuation, dividends and analyst recommendations.

Risk and Volatility

Adagio Medical has a beta of 0.21, suggesting that its stock price is 79% less volatile than the S&P 500. Comparatively, Autonomix Medical has a beta of -5.4, suggesting that its stock price is 640% less volatile than the S&P 500.

Insider and Institutional Ownership

48.1% of Adagio Medical shares are owned by institutional investors. Comparatively, 10.8% of Autonomix Medical shares are owned by institutional investors. 53.5% of Adagio Medical shares are owned by insiders. Comparatively, 32.4% of Autonomix Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Adagio Medical and Autonomix Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Adagio Medical	N/A	160.59%	40.99%
Autonomix Medical	N/A	-212.48%	-161.13%

Valuation & Earnings

This table compares Adagio Medical and Autonomix Medical”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Adagio Medical	$266,000.00	62.45	-$2.13 million	N/A	N/A
Autonomix Medical	N/A	N/A	-$15.43 million	($12.93)	-0.14

Adagio Medical has higher revenue and earnings than Autonomix Medical.

Analyst Recommendations

This is a summary of recent ratings and price targets for Adagio Medical and Autonomix Medical, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Adagio Medical	0	0	0	0	0.00
Autonomix Medical	0	0	1	0	3.00

Autonomix Medical has a consensus price target of $28.00, suggesting a potential upside of 1,413.51%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, analysts clearly believe Autonomix Medical is more favorable than Adagio Medical.

Summary

Adagio Medical beats Autonomix Medical on 7 of the 10 factors compared between the two stocks.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.